Yahoo! Video requires a more recent version of the Adobe Flash Player.
From
Published 6 months ago
Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescription formulation. Novartis announced today that Prevacid® 24HR (lansoprazole delayed-release capsules 15 mg) has been... more
Novartis receives approval from FDA to market Prevacid(R) 24HR as first and only OTC proton pump inhibitor in original prescription formulation. Novartis announced today that Prevacid® 24HR (lansoprazole delayed-release capsules 15 mg) has been approved by the U.S. Food and Drug Administration (FDA) as the first over-the-counter (OTC) Proton Pump Inhibitor (PPI) for the treatment of frequent heartburn since 2003. Prevacid 24HR is expected to be available over-the-counter in 2009. To view Multimedia News Release, go to http://www.prnewswire.com/mnr/prevacid/38457/ less
Tell us what you think about Yahoo! Video - Send us your feedback
Copyright © 2009 Yahoo! Inc. All rights reserved.
Comments (0)
LOADING
Add a new comment
Your reply